Aditx Therapeutics Inc (ADTX)
Aditx Therapeutics Inc (ADTX) is a biotechnology company whose common stock trades on OTC Markets. This overview refers to the listed common equity security in the OTC Markets setting, rather than a fund, note, or other pooled instrument. The company is associated with biopharmaceutical research and development, with activity centered on immune-related diagnostics and therapeutic concepts. Its work has also been described in terms of molecular testing and other early-stage life sciences programs. Because this is a common stock listing, the security represents equity in the issuer and is subject to the risks typical of OTC-listed biotechnology shares.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-ADTX
|
$0.0058
|
26.1% Upside
|
Undervalued
|
Not available
|
Not available
|
Weak
|
0.0%
|
November 19, 2026
|
0.3x
|
3.753 K
|
2.072 M
|
180.9%
|
22.3%
|
-29.3
|
34.8%
|
